Cucurbitacin B's Effects on Breast Cancer Cells
Author Information
Author(s): Duangmano Suwit, Dakeng Sumana, Jiratchariyakul Weena, Suksamrarn Apichart, Smith Duncan R., Patmasiriwat Pimpicha
Primary Institution: Mahidol University
Hypothesis
Cucurbitacin B inhibits telomerase activity and affects cell cycle progression in breast cancer cells.
Conclusion
Cucurbitacin B inhibits growth and telomerase activity in breast cancer cells, particularly in estrogen receptor-negative SKBR-3 cells.
Supporting Evidence
- Cucurbitacin B significantly inhibited cell growth in SKBR-3 and HBL-100 cells.
- Telomerase activity was reduced in all tested breast cancer cell lines after treatment with cucurbitacin B.
- SKBR-3 cells showed the greatest sensitivity to cucurbitacin B compared to other cell lines.
Takeaway
Cucurbitacin B, a substance from a Thai herb, helps stop breast cancer cells from growing by blocking a process that helps them divide.
Methodology
The study used cell viability assays, TRAP assays, and RT-PCR to assess the effects of cucurbitacin B on breast cancer cell lines.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website